Ms. Harris has spent the last 12 years in the biopharmaceutical industry developing and implementing commercialization strategies in a variety of therapeutic areas including rare genetic disorders, infections diseases and oncology. Her experience includes product launches, product and clinical development planning, international subsidiary P&L, new product planning, line management, and management of day-to-day commercial operations. The majority of her tenure was with The Liposome Company (acquired by �lan Corporation) where she held a variety of positions including Executive Director of Marketing, Education and Professional Services and as Senior Director Hospital Marketing with �lan. Ms. Harris joined Sopherion in September 2004 from Genzyme Corporation where she held a Senior Director of Global Marketing position in the Lysosomal Storage Disorders business unit.